Senate Appropriators Worry About US FDA Gene Therapy, Complex Generic Approval Pace

 
• By Derrick Gingery
  
Artificial Intelligence
Senators want the FDA to consider artificial intelligence to help find complete generic application deficiencies quicker. • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies